The 24th of March 2022, Catalent Biologics completed $30 million (€27 million) project at its facility in Limoges, France, to transform the site into a European center of excellence for biopharmaceutical development, drug product fill/finish services, and packaging.
The project has seen a complete modernization of the Limoges site.A new small-to-mid-scale flexible filling line has been installed.